Loading…
Based on limited metadata, PT. MegaSurya Mas, a pharmaceutical company, received an FDA Warning Letter on August 24, 2020 regarding drug products. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning pertains to drug manufacturing or compliance issues under FDA regulatory authority, though the precise issuing office and violation details remain unavailable.